60 Degrees Pharmaceuticals (SXTP) Prepaid Assets (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Prepaid Assets of $1.7 million for Q1 2026, up 78.85% year-over-year from $937250.0 in Q1 2025, and up 71.37% quarter-over-quarter from $978131.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Prepaid Assets (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Prepaid Assets for 5 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 78.85% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 78.85% YoY), while the FY2025 annual figure was $978131.0, down 8.5% from the prior year.
- Prepaid Assets improved to $1.7 million in Q1 2026 per SXTP's latest filing, from $978131.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.8 million in Q2 2023 and bottomed at $176471.0 in Q3 2024.
- Historically, Prepaid Assets has averaged $1.8 million across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 2090.71% — and 2024, when it slumped 83.4%.
- 60 Degrees Pharmaceuticals' Prepaid Assets stood at $200967.0 in 2022, then soared by 2090.71% to $4.4 million in 2023, then slumped by 75.72% to $1.1 million in 2024, then dropped by 8.5% to $978131.0 in 2025, then surged by 71.37% to $1.7 million in 2026.
- Business Quant data shows SXTP's Prepaid Assets at $1.7 million in Q1 2026, $978131.0 in Q4 2025, and $992390.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 978,131.00 |
| Sep 30, 2025 | 992,390.00 |
| Jun 30, 2025 | 782,970.00 |
| Mar 31, 2025 | 937,250.00 |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 176,471.00 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 4.40 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 4.85 Mn |
| Dec 31, 2022 | 200,967.00 |